News

WY Biotech is now obligated to pay a $7 million upfront license fee to HCW Biologics by Sept. 30, according to a filing with the Securities and Exchange Commission. HCW Biologics previously said it ...
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...
Sarepta stock crashed Friday on reports the FDA will ask the biotech company to stop shipments of its approved gene therapy, ...
Clinical-stage biotech stocks carry significant risks, but also offer explosive upside potential. These companies are built ...
The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...